These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 5858505)
1. A critique of the use of drugs to achieve coronary vasodilation. Bernstein A; Simon F Vasc Dis; 1965 Nov; 2(6):357-64. PubMed ID: 5858505 [No Abstract] [Full Text] [Related]
3. [The effectiveness of treating patients with coronary insufficiency with verapamil]. Kipsidze NN; Capidze GJ Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1284+. PubMed ID: 5536553 [No Abstract] [Full Text] [Related]
4. [The use of a combination of di-isopropylammonium dichlorethanoate (Diedi) and pentaerythrol tetranitrate (Nitrate) in the treatment of coronary disease. Clinical electrocerdiographic and coronarographic remarks]. Tronconi L; Baldrighi G; Massoni G; Calderoni AG; Baldrighi V Minerva Cardioangiol; 1967 Mar; 15(3):211-7. PubMed ID: 5604123 [No Abstract] [Full Text] [Related]
6. [Application of a coronary vasodilator, Intensain in clinical anesthesia]. Dan K Masui; 1967 Jan; 16(1):61-5. PubMed ID: 6068641 [No Abstract] [Full Text] [Related]
7. [Clinical and electrocardiographic study on the coronary active action of tetranitrooxyethylethylenediamine dinitrate]. Bianchini E; De Maestri C; Rinaldi AR Boll Soc Med Chir Cremona; 1966; 20(2):161-76. PubMed ID: 5961319 [No Abstract] [Full Text] [Related]
8. [Effect of hexobendin in coronary diseases]. Varela de Seijas y Agui ; González Peña JJ; González García L Rev Clin Esp; 1968 Apr; 109(2):147-52. PubMed ID: 5741634 [No Abstract] [Full Text] [Related]
9. [Treatment of heart and coronary insufficiency with Intensain Lanicor]. Kligge H Munch Med Wochenschr; 1966 May; 108(21):1169-76. PubMed ID: 6014174 [No Abstract] [Full Text] [Related]
13. [Clinical and electrocardiographic studies on Ustimon treatment]. Leibetseder F Wien Klin Wochenschr; 1965 Oct; 77(43):839-44. PubMed ID: 5874523 [No Abstract] [Full Text] [Related]
14. [Value of carbocromene in the treatment of coronary disease. Clinical and electrocardiographic data (a case)]. Richard A; Vaudeleau M Sem Ther; 1968 Mar; 44(3):180-2. PubMed ID: 5741350 [No Abstract] [Full Text] [Related]
15. Vasodilator therapy in coronary artery disease. Part III. Hager WD Ariz Med; 1977 Aug; 34(8):565-7. PubMed ID: 901250 [No Abstract] [Full Text] [Related]
16. Drugs in coronary artery diseases. Chand A J Indian Med Assoc; 1969 Oct; 53(7):356-62. PubMed ID: 5368376 [No Abstract] [Full Text] [Related]
17. [On the objective evaluation of the effects of coronary vasoactive drugs]. Lenti G; Cherchi A; Raffo M; Porrazzo G Minerva Med; 1966 Feb; 57(12):455-9. PubMed ID: 5910815 [No Abstract] [Full Text] [Related]
18. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow. Topal E; Ozdemir R; Barutcu I; Aksoy Y; Sincer I; Akturk E; Cehreli S J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422 [TBL] [Abstract][Full Text] [Related]
19. [The role of vasodilators in the treatment of congestive heart failure and myocardial ischaemia (author's transl)]. Tarnow J Anaesthesist; 1981 Jun; 30(6):269-79. PubMed ID: 6791517 [TBL] [Abstract][Full Text] [Related]